Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Users Online: 1265


Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Advertise Contacts Login 

    Article Cited by others


Immunohistochemical expression of vimentin in invasive breast carcinoma and its correlation with clinicopathological parameters

Khillare Chaitnya D, Sinai Khandeparkar Siddhi Gaurish, Joshi Avinash R, Kulkarni Maithili M, Gogate Bageshri P, Battin Shivani

Year : 2019| Volume: 60| Issue : 1 | Page no: 17-21

   This article has been cited by
1 Prognostic Value of Vimentin in Triple Negative Breast Cancer Patients Depends on Chemotherapy Regimen and p53 Mutant Expression
Ibnu Purwanto, Benedreky Leo, Susanna Hilda Hutajulu, Johan Kurnianda, Kartika Widayati Taroeno-Hariadi, Mardiah Suci Hardianti, Amanda Dania Satiti, Ery Kus Dwianingsih, Didik Setyo Heriyanto, Irianiwati Widodo, Teguh Aryandono
Breast Cancer: Targets and Therapy. 2023; Volume 15: 515
[Pubmed]  [Google Scholar] [DOI]
2 Proteomics-Based Identification of Dysregulated Proteins and Biomarker Discovery in Invasive Ductal Carcinoma, the Most Common Breast Cancer Subtype
Anca-Narcisa Neagu, Danielle Whitham, Logan Seymour, Norman Haaker, Isabella Pelkey, Costel C. Darie
Proteomes. 2023; 11(2): 13
[Pubmed]  [Google Scholar] [DOI]
3 Proteomics-Based Identification of Dysregulated Proteins in Breast Cancer
Anca-Narcisa Neagu, Madhuri Jayathirtha, Danielle Whitham, Panashe Mutsengi, Isabelle Sullivan, Brindusa Alina Petre, Costel C. Darie
Proteomes. 2022; 10(4): 35
[Pubmed]  [Google Scholar] [DOI]
4 Evaluation of the Role of hsa-mir-124 in Predicting Clinical Outcome in Breast Invasive Carcinoma Based on Bioinformatics Analysis
Tongbao Feng,Ping Zhang,Yingxin Sun,Xiu Han,Jichun Tong,Zichun Hua
BioMed Research International. 2020; 2020: 1
[Pubmed]  [Google Scholar] [DOI]


Read this article